Your browser doesn't support javascript.
loading
Interferon-alpha responsible EPN3 regulates hepatitis B virus replication.
Li, Xueqian; Wang, Zhe; Zhou, Weiping; Fu, Xuanhe; Zhang, Yunpeng; Sun, Ye; Yang, Biao; Bai, Yuxin; Dai, Chunwei; Xu, Xiaolun; Cui, Fan; Zhao, Ying; Zhang, Yuping; Wang, Bengang; Li, Yingfang; Muramatsu, Masamichi; Wakae, Kousho; Liu, Guangyan.
Afiliação
  • Li X; Department of Pathogen Biology, Shenyang Medical College, Shenyang, China.
  • Wang Z; Department of Medical Oncology, Affiliated Zhongshan Hospital of Dalian University, Dalian, China.
  • Zhou W; The Key Laboratory of Biomarker High Throughput Screening and Target Translation of Breast and Gastrointestinal Tumor, Dalian University, Dalian, China.
  • Fu X; Department of Pathogen Biology, Shenyang Medical College, Shenyang, China.
  • Zhang Y; Department of Immunology, Shenyang Medical College, Shenyang, China.
  • Sun Y; Department of Pathophysiology, Shenyang Medical College, Shenyang, China.
  • Yang B; Department of Pathogen Biology, Shenyang Medical College, Shenyang, China.
  • Bai Y; Department of Pathogen Biology, Shenyang Medical College, Shenyang, China.
  • Dai C; Department of Pathogen Biology, Shenyang Medical College, Shenyang, China.
  • Xu X; College of Basic Medical Sciences, Shenyang Medical College, Shenyang, China.
  • Cui F; Department of Pathogen Biology, Shenyang Medical College, Shenyang, China.
  • Zhao Y; College of Basic Medical Sciences, Shenyang Medical College, Shenyang, China.
  • Zhang Y; College of Basic Medical Sciences, Shenyang Medical College, Shenyang, China.
  • Wang B; College of Basic Medical Sciences, Shenyang Medical College, Shenyang, China.
  • Li Y; Department of Hepatobiliary Surgery, Institute of General Surgery, The First Hospital of China Medical University, Shenyang, China.
  • Muramatsu M; Department of Virology II, National Institute of Infectious Disease, Tokyo, Japan.
  • Wakae K; Department of Virology II, National Institute of Infectious Disease, Tokyo, Japan.
  • Liu G; Foundation for Biomedical Research and Innovation, Kobe, Japan.
Front Med (Lausanne) ; 9: 944489, 2022.
Article em En | MEDLINE | ID: mdl-35935763
ABSTRACT
Hepatitis B virus (HBV) infection remains a major health problem worldwide, and the current antiviral therapy, including nucleoside analogs, cannot achieve life-long cure, and clarification of antiviral host immunity is necessary for eradication. Here, we found that a clathrin-binding membrane protein epsin3 (EPN3) negatively regulates the expression of HBV RNA. EPN3 expression was induced by transfection of an HBV replicon plasmid, and reduced HBV-RNA level in hepatic cell lines and murine livers hydrodynamically injected with the HBV replicon plasmid. Viral RNA reduction by EPN3 was dependent on transcription, and independent from epsilon structure of viral RNA. Viral RNA reduction by overexpression of p53 or IFN-α treatment, was attenuated by knockdown of EPN3, suggesting its role downstream of IFN-α and p53. Taken together, this study demonstrates the anti-HBV role of EPN3. The mechanism how it decreases HBV transcription is discussed.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article